Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasper B Hansen

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Molecular Pharmacology|February 25, 2026
UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptorsAvery J Benton, Mia R Johns, Emil Diamant, et al.
Journal of Medicinal Chemistry|December 23, 2016
Development of Radiolabeled Ligands Targeting the Glutamate Binding Site of the N-Methyl-d-aspartate Receptor as Potential Imaging Agents for BrainLucia Tamborini, Ying Chen, Catherine A Foss, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptorsAvery J Benton, Mia R Johns, Emil Diamant, et al.
Journal of Medicinal Chemistry|April 23, 2010
4-hydroxy-1,2,5-oxadiazol-3-yl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and molecular pharmacological characterization at ionotropic glutamate receptors of compounds related to glutamate and its homologuesMarco L Lolli, Cecilia Giordano, Darryl S Pickering, et al.
Nature Cardiovascular Research|July 17, 2025
The thrombin receptor PAR1 orchestrates changes in lymphatic endothelial cell junction morphology to augment lymphatic drainage during lung injuryChou Chou, Camila Ceballos Paredes, Barbara Summers, et al.
Journal of Medicinal Chemistry|June 27, 2008
N-Hydroxypyrazolyl glycine derivatives as selective N-methyl-D-aspartic acid receptor ligandsRasmus P Clausen, Caspar Christensen, Kasper B Hansen, et al.
Molecular Pharmacology|August 3, 2011
Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulatorsTimothy M Acker, Hongjie Yuan, Kasper B Hansen, et al.
Chemmedchem|July 29, 2010
Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: design, synthesis, and pharmacological characterizationPaola Conti, Andrea Pinto, Lucia Tamborini, et al.
Journal of Medicinal Chemistry|December 6, 2017
Augmentation of Anticancer Drug Efficacy in Murine Hepatocellular Carcinoma Cells by a Peripherally Acting Competitive N-Methyl-d-aspartate (NMDA) Receptor AntagonistMikko Gynther, Ilaria Proietti Silvestri, Jacob C Hansen, et al.
Nature Communications|October 29, 2010
A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptorsPraseeda Mullasseril, Kasper B Hansen, Katie M Vance, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Molecular Pharmacology|February 25, 2026
UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptorsAvery J Benton, Mia R Johns, Emil Diamant, et al.
Journal of Medicinal Chemistry|December 23, 2016
Development of Radiolabeled Ligands Targeting the Glutamate Binding Site of the N-Methyl-d-aspartate Receptor as Potential Imaging Agents for BrainLucia Tamborini, Ying Chen, Catherine A Foss, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
UCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptorsAvery J Benton, Mia R Johns, Emil Diamant, et al.
Journal of Medicinal Chemistry|April 23, 2010
4-hydroxy-1,2,5-oxadiazol-3-yl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and molecular pharmacological characterization at ionotropic glutamate receptors of compounds related to glutamate and its homologuesMarco L Lolli, Cecilia Giordano, Darryl S Pickering, et al.
Nature Cardiovascular Research|July 17, 2025
The thrombin receptor PAR1 orchestrates changes in lymphatic endothelial cell junction morphology to augment lymphatic drainage during lung injuryChou Chou, Camila Ceballos Paredes, Barbara Summers, et al.
Journal of Medicinal Chemistry|June 27, 2008
N-Hydroxypyrazolyl glycine derivatives as selective N-methyl-D-aspartic acid receptor ligandsRasmus P Clausen, Caspar Christensen, Kasper B Hansen, et al.
Molecular Pharmacology|August 3, 2011
Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulatorsTimothy M Acker, Hongjie Yuan, Kasper B Hansen, et al.
Chemmedchem|July 29, 2010
Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: design, synthesis, and pharmacological characterizationPaola Conti, Andrea Pinto, Lucia Tamborini, et al.
Journal of Medicinal Chemistry|December 6, 2017
Augmentation of Anticancer Drug Efficacy in Murine Hepatocellular Carcinoma Cells by a Peripherally Acting Competitive N-Methyl-d-aspartate (NMDA) Receptor AntagonistMikko Gynther, Ilaria Proietti Silvestri, Jacob C Hansen, et al.
Nature Communications|October 29, 2010
A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptorsPraseeda Mullasseril, Kasper B Hansen, Katie M Vance, et al.
Pageof 9